Literature DB >> 15755806

Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes.

Tomás Vacík1, Michael Ort, Sona Gregorová, Petr Strnad, Radek Blatny, Nathalie Conte, Allan Bradley, Jan Bures, Jirí Forejt.   

Abstract

Triplication of whole autosomes or large autosomal segments is detrimental to the development of a mammalian embryo. The trisomy of human chromosome (Chr) 21, known as Down's syndrome, is regularly associated with mental retardation and a variable set of other developmental anomalies. Several mouse models of Down's syndrome, triplicating 33-104 genes of Chr16, were designed in an attempt to analyze the contribution of specific orthologous genes to particular developmental features. However, a recent study challenged the concept of dosage-sensitive genes as a primary cause of an abnormal phenotype. To distinguish between the specific effects of dosage-sensitive genes and nonspecific effects of a large number of arbitrary genes, we revisited the mouse Ts43H/Ph segmental trisomy. It encompasses >310 known genes triplicated within the proximal 30 megabases (Mb) of Chr17. We refined the distal border of the trisomic segment to the interval bounded by bacterial artificial chromosomes RP23-277B13 (location 29.0 Mb) and Cbs gene (location 30.2 Mb). The Ts43H mice, viable on a mixed genetic background, exhibited spatial learning deficits analogous to those observed in Ts65Dn mice with unrelated trisomy. Quantitative analysis of the brain expression of 20 genes inside the trisomic interval and 12 genes lying outside on Chr17 revealed 1.2-fold average increase of mRNA steady-state levels of triplicated genes and 0.9-fold average down-regulation of genes beyond the border of trisomy. We propose that systemic comparisons of unrelated segmental trisomies, such as Ts65Dn and Ts43H, will elucidate the pathways leading from the triplicated sequences to the complex developmental traits.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15755806      PMCID: PMC552979          DOI: 10.1073/pnas.0500802102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Too much of a good thing: mechanisms of gene action in Down syndrome.

Authors:  R H Reeves; L L Baxter; J T Richtsmeier
Journal:  Trends Genet       Date:  2001-02       Impact factor: 11.639

2.  Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain.

Authors:  Rong Mao; Carol L Zielke; H Ronald Zielke; Jonathan Pevsner
Journal:  Genomics       Date:  2003-05       Impact factor: 5.736

3.  Recent segmental duplications in the human genome.

Authors:  Jeffrey A Bailey; Zhiping Gu; Royden A Clark; Knut Reinert; Rhea V Samonte; Stuart Schwartz; Mark D Adams; Eugene W Myers; Peter W Li; Evan E Eichler
Journal:  Science       Date:  2002-08-09       Impact factor: 47.728

4.  Genomics. Gene duplication and evolution.

Authors:  Michael Lynch
Journal:  Science       Date:  2002-08-09       Impact factor: 47.728

5.  Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome.

Authors:  Z Rahmani; J L Blouin; N Creau-Goldberg; P C Watkins; J F Mattei; M Poissonnier; M Prieur; Z Chettouh; A Nicole; A Aurias
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

6.  The induction of translocations in mouse spermatozoa. I. Kinetics of dose response with acute x-irradiation.

Authors:  A G Searle; C E Ford; E P Evans; C V Beechey; M D Burtenshaw; H M Clegg; D G Papworth
Journal:  Mutat Res       Date:  1974-02       Impact factor: 2.433

7.  Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.

Authors:  D M Holtzman; D Santucci; J Kilbridge; J Chua-Couzens; D J Fontana; S E Daniels; R M Johnson; K Chen; Y Sun; E Carlson; E Alleva; C J Epstein; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

8.  Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome.

Authors:  Pascal Kahlem; Marc Sultan; Ralf Herwig; Matthias Steinfath; Daniela Balzereit; Barbara Eppens; Nidhi G Saran; Mathew T Pletcher; Sarah T South; Gail Stetten; Hans Lehrach; Roger H Reeves; Marie-Laure Yaspo
Journal:  Genome Res       Date:  2004-07       Impact factor: 9.043

9.  Allele-specific expression and total expression levels of imprinted genes during early mouse development: implications for imprinting mechanisms.

Authors:  P E Szabó; J R Mann
Journal:  Genes Dev       Date:  1995-12-15       Impact factor: 11.361

10.  Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome.

Authors:  R M Escorihuela; I F Vallina; C Martínez-Cué; C Baamonde; M Dierssen; A Tobeña; J Flórez; A Fernández-Teruel
Journal:  Neurosci Lett       Date:  1998-05-15       Impact factor: 3.046

View more
  20 in total

1.  Chromosomal rearrangement interferes with meiotic X chromosome inactivation.

Authors:  David Homolka; Robert Ivanek; Jana Capkova; Petr Jansa; Jiri Forejt
Journal:  Genome Res       Date:  2007-08-23       Impact factor: 9.043

Review 2.  Aneuploidy: cells losing their balance.

Authors:  Eduardo M Torres; Bret R Williams; Angelika Amon
Journal:  Genetics       Date:  2008-06       Impact factor: 4.562

Review 3.  New insights into the troubles of aneuploidy.

Authors:  Jake J Siegel; Angelika Amon
Journal:  Annu Rev Cell Dev Biol       Date:  2012-07-09       Impact factor: 13.827

Review 4.  Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse models.

Authors:  Y Eugene Yu; Zhuo Xing; Catherine Do; Annie Pao; Eun Joon Lee; Sharon Krinsky-McHale; Wayne Silverman; Nicole Schupf; Benjamin Tycko
Journal:  Prog Brain Res       Date:  2019-10-24       Impact factor: 2.453

Review 5.  Short- and long-term effects of chromosome mis-segregation and aneuploidy.

Authors:  Stefano Santaguida; Angelika Amon
Journal:  Nat Rev Mol Cell Biol       Date:  2015-08       Impact factor: 94.444

6.  Genes and Small RNA Transcripts Exhibit Dosage-Dependent Expression Pattern in Maize Copy-Number Alterations.

Authors:  Tao Zuo; Jianbo Zhang; Andrew Lithio; Sudhansu Dash; David F Weber; Roger Wise; Dan Nettleton; Thomas Peterson
Journal:  Genetics       Date:  2016-04-29       Impact factor: 4.562

Review 7.  Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.

Authors:  Sébastien Malinge; Shai Izraeli; John D Crispino
Journal:  Blood       Date:  2009-01-12       Impact factor: 22.113

Review 8.  Aneuploidy and gene expression: is there dosage compensation?

Authors:  Shihoko Kojima; Daniela Cimini
Journal:  Epigenomics       Date:  2019-11-22       Impact factor: 4.778

Review 9.  Molecular genetic analysis of Down syndrome.

Authors:  David Patterson
Journal:  Hum Genet       Date:  2009-06-13       Impact factor: 4.132

Review 10.  Gene copy-number alterations: a cost-benefit analysis.

Authors:  Yun-Chi Tang; Angelika Amon
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.